Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2008
10/22/2008EP1981994A2 Sers nanotag assays
10/22/2008EP1981899A1 Oligonucleotide synthesis using photocleavable linkers
10/22/2008EP1794307A4 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use
10/22/2008EP0970199B1 Fluorescent protein sensors for detection of analytes
10/22/2008EP0861262B1 Nucleic acid capture moieties
10/22/2008EP0828519B1 Recombinant viral vector system
10/22/2008CN101292033A Multivalent rna nanoparticles for delivery of active agents to a cell
10/22/2008CN101291949A Aptamers comprising arabinose modified nucleotides
10/22/2008CN101291948A Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
10/22/2008CN101289486A Process for synthesizing RNA monomer
10/22/2008CN101289485A Absorption of nucleic acids to solid phases under low-salt conditions
10/22/2008CN100427592C Method for establishing mouse full-genome mutoation ES cell bank
10/22/2008CN100427591C Method for screening and establishing mouse-development-related gene mutation ES cell bank
10/21/2008US7439419 To inhibit SGT3 activity and reduce the levels of the steroidal glycoalkaloids alpha -chaconine and alpha -solanine in Solanaceous plants such as potato; reduce or eliminate glycoalkaloid biosynthesis during storage and shipping
10/21/2008US7439417 Transcription factor stress-related proteins and methods of use in plants
10/21/2008US7439416 Indeterminate gametophyte 1 (ig1)gene from Zea mays and uses thereof
10/21/2008US7439346 Nucleic acids arrays and methods of use therefor
10/21/2008US7439345 Supramolecular pairing system, its preparation and use
10/21/2008US7439341 Monitoring polymerase chain reactions
10/21/2008US7439332 expression product of the nucleic acid, a polymer conjugated drug with increased stability of the protein in vivo; stimulating the production of erythrocyte progenitor cells in culture or in vivo
10/21/2008US7439325 PRO6001 polypeptides
10/21/2008US7439230 Extracellular domain of CTLA4, with (a) an alanine at position +29 substituted with tyrosine, leucine, tryptophan, or threonine, and (b) a leucine at position +104 substituted with glutamic acid; binds CD80 and/or CD86 with greater avidity; inhibiting graft versus host disease
10/21/2008US7439067 Isolated polynucleotides and methods of promoting a morphology in a fungus
10/21/2008US7439061 DNA encoding the novel mammalian protein, Ire1p
10/21/2008US7439059 Compositions and methods for activating genes of interest
10/21/2008US7439058 For use in vaccines
10/21/2008US7439050 Corynebacterium glutamicum genes encoding diaminopimelate epimerase
10/21/2008US7439049 Isolated polypeptide with glycosyl transferase enzymatic activity for producing dextrans with alpha (1 --> 2) sidechains, comprising at least one region for bonding to glucan and a catalytically active region situated beyond the region bonding to glucan; expression vectors; genetic engineering
10/21/2008US7439034 Alginases, systems containing alginases and methods of cloning, purifying and/or utilizing alginases
10/21/2008US7439023 Method of isolating a nucleic acid using a material containing an amino group and a carboxyl group and positively charged at a first pH and a solid material for nucleic acid isolation used for the method
10/21/2008US7439022 Nucleic acids for detection of Listeria
10/21/2008US7439021 Nucleic acid cloning
10/21/2008US7439020 presence of 31C, 53C, 312C, 799G, 961G, 1165T, 1499G, 1613A, 1762T, 1764A, 1899A, 2170C, 2170G, 2441C, 2525C, 2712C, 2712A, or 2712G nucleotides in an HBV genome is associated with the development of hepatocellular carcinoma
10/21/2008US7439019 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction
10/21/2008US7439016 Detection of nucleic acids by type-specific hybrid capture method
10/21/2008US7438916 Therapeutic target for protozoal diseases
10/21/2008US7438912 isolated hyperimmune serum-reactive antigen fragment; and an immunostimulant; nucleic acid molecule isolated from a S. agalactiae genomic DNA; Group B Streptococci
10/21/2008CA2330974C Energy transfer assay method and reagent
10/21/2008CA2289776C An infectious clone for human parainfluenza virus type 3
10/21/2008CA2232242C Long wavelength engineered fluorescent proteins
10/21/2008CA2230452C Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
10/21/2008CA2162361C Antisense oligonucleotides which combat aberrant splicing and methods of using the same
10/20/2008CA2629589A1 Isolation and purification of nucleic acid molecules with a solid phase
10/20/2008CA2629586A1 Adsorption of nucleic acids to solid phases under low-salt conditions
10/19/2008CA2629465A1 Method for detecting and/or isolating mycobacteria
10/16/2008WO2008124466A1 Urotensin 2 and its receptor as candidate genes for beef marbling score, ribeye area and fatty acid composition
10/16/2008WO2008124331A1 Novel sequences and dna vaccines against avian flu
10/16/2008WO2008124187A1 Biochemical markers for disease states and genes for identification of biochemical defects
10/16/2008WO2008124170A2 SELECTION OF HUMAN TNFα SPECIFIC ANTIBODIES
10/16/2008WO2008124119A1 Improved methods and compositions for determining the pathogenic status of infectious agents
10/16/2008WO2008122088A1 Methods for detecting a target nucleotide sequence in a sample utilising a nuclease-aptamer complex
10/16/2008WO2008094945A3 Compounds and methods for modulating protein expression
10/16/2008WO2008089394A3 Mycobacterium tuberculosis persistance genes
10/16/2008WO2008088882A3 Methods of generating cardiomyocytes
10/16/2008WO2008088548A3 Disintegrin variants and pharmaceutical uses thereof
10/16/2008WO2008085991A3 Reaction chamber
10/16/2008WO2008085777A3 A method for early detection of cancer
10/16/2008WO2008073624A3 Quantitative nucleic acid hybridization using magnetic luminescent particles
10/16/2008WO2008073175A3 Nanoplasmonic molecular ruler for nuclease activity and dna footprinting
10/16/2008WO2008070223A3 A method to remove repetitive sequences from human dna
10/16/2008WO2008066608A3 A secreted luciferase fluorescent protein conjugate nucleic acid construct and uses thereof
10/16/2008WO2008063493A3 Compositions and methods related to toll-like receptor-3
10/16/2008WO2008054561A3 Proteins, nucleic acids encoding the same and associated methods of use
10/16/2008WO2008045977A3 Beta-xylosidase for conversion of plant cell wall carbohydrates to simple sugars
10/16/2008WO2008045251A3 Snap-back primers and detectable hairpin structures
10/16/2008WO2008030619A3 Pcr-based genotyping
10/16/2008WO2008027899A3 Methods and compositions related to apobec-1 expression
10/16/2008WO2008019351A3 Compositions and their uses directed to diacylglycerol acyltransferase 1
10/16/2008WO2008011234A3 Recombinant host for producing l-asparaginase ii
10/16/2008WO2007149141A3 C1-inactivator inhibits two-chain urokinase mutant and limits hemostatic bleeding during thromolysis
10/16/2008WO2007146819A3 Methods for identifying and using snp panels
10/16/2008WO2007140195A3 Methods and systems for increasing production of equilibrium reactions
10/16/2008WO2007130423A3 Biological markers of chronic wound tissue and methods of using for criteria in surgical debridement
10/16/2008WO2007123761A3 Methylation of estrogen receptor alpha and uses thereof
10/16/2008WO2007120932A3 Expression of o-glycosylated therapeutic proteins in prokaryotic microorganisms
10/16/2008WO2007102872A3 Compositions and methods related to controlled gene expression using viral vectors
10/16/2008WO2007100578A3 A simplified qtl mapping approach for screening and mapping novel markers associated with beef marbling
10/16/2008WO2007095352A3 Diagnosis and treatment of attentional disorders
10/16/2008WO2007094924A3 Human telomerase reverse transcriptase peptides
10/16/2008WO2007092941A3 Sers nanotag assays
10/16/2008WO2007087576A3 Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases
10/16/2008WO2007073523A3 MITIGATION OF Cot-1 DNA DISTORTION IN NUCLEIC ACID HYBRIDIZATION
10/16/2008WO2006138324A3 Treponema pallidum antigens for vaccine development and diagnostic tests
10/16/2008WO2006036613A3 Mracs as modifiers of the rac pathway and methods of use
10/16/2008WO2005047462A3 Universal control for nucleic acid amplification
10/16/2008WO2005003319A3 Glucanases, nucleic acids encoding them and methods for making and using them
10/16/2008US20080256663 Nucleic acid molecules and other molecules associated with plants
10/16/2008US20080256662 Nucleic acid molecules and other molecules associated with plants
10/16/2008US20080256649 Insect hydrolase for use as tool in identifying modulators which prevent mosquito propagation; genetic detection of resistance to organophosphorus and/or carbamates pesticides
10/16/2008US20080255345 IRNA Agents Targeting CCR5 Expressing Cells And Uses Thereof
10/16/2008US20080255065 In combination with one or more anti-cancer therapeutics inhibits neoplastic cell proliferation; siRNA molecule decreased gemcitabine chemoresistance of pancreatic adenocarcinoma cells in vivo, demonstrating a synergistic effect when administered in combination with gemcitabine
10/16/2008US20080255045 Modified FGF-21 Polypeptides and Their Uses
10/16/2008US20080255040 Polypeptide with amino acid sequences including exogenous glycosylated sequences; libraries
10/16/2008US20080255039 Peptide which is part of epitope in human IL-15 responsible for high-affinity binding of IL-15 to IL-15Ralpha chain, characterized in that it has sequence of region of human mature wild-type IL-15 from L44 to L52, or sequence of region of human mature wild-type IL-15 from E64 to I68 or from E64 to L69
10/16/2008US20080255025 Protease inhibition
10/16/2008US20080255005 A two-dimensional matrix for dispersing the probe beads in a thixotropic agent, a scanner, and a spot-picker that isolates the target biomolecule; high throughput assays
10/16/2008US20080254999 Linear nucleic acid and sequence therefor
10/16/2008US20080254994 Classification and diagnosis of the molecular basis of cholestasis
10/16/2008US20080254551 Using support immobilized immunmoglobulin fusions as separation and classification tools in screening fluids for preferential analytes
10/16/2008US20080254539 Enhanced hydrolase comprising asparagine to aspartic acid mutation; for use improving rumen digestion
1 ... 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 ... 899